Published in Catheter Cardiovasc Interv on June 01, 2002
Low diagnostic yield of elective coronary angiography. N Engl J Med (2010) 9.38
Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med (2013) 7.00
Percutaneous repair or surgery for mitral regurgitation. N Engl J Med (2011) 5.78
Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation (2003) 5.34
2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2014) 4.57
Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation (2005) 3.83
The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes. Ann Intern Med (2004) 3.78
Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management. Circulation (2004) 2.73
2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2014) 2.30
Frequent diagnostic errors in cardiac PET/CT due to misregistration of CT attenuation and emission PET images: a definitive analysis of causes, consequences, and corrections. J Nucl Med (2007) 2.29
Intravascular photoacoustic imaging using an IVUS imaging catheter. IEEE Trans Ultrason Ferroelectr Freq Control (2007) 2.14
Spectroscopic intravascular photoacoustic imaging to differentiate atherosclerotic plaques. Opt Express (2008) 2.07
Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy. Circulation (2004) 2.05
Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction. J Mol Cell Cardiol (2007) 2.04
Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast. Catheter Cardiovasc Interv (2003) 1.76
Total ischemic time: the correct focus of attention for optimal ST-segment elevation myocardial infarction care. JACC Cardiovasc Interv (2011) 1.75
The Carotid Artery Revascularization and Endarterectomy (CARE) registry: objectives, design, and implications. Catheter Cardiovasc Interv (2008) 1.75
Obesity in diabetic patients undergoing coronary artery bypass graft surgery is associated with increased postoperative morbidity. Anesthesiology (2006) 1.70
Regional myocardial deformation in children with hypertrophic cardiomyopathy: morphological and clinical correlations. Eur Heart J (2007) 1.70
The dilemma of success: percutaneous coronary interventions in patients > or = 75 years of age-successful but associated with higher vascular complications and cardiac mortality. Catheter Cardiovasc Interv (2003) 1.63
Outcome of access site in patients treated with platelet glycoprotein IIb/IIIa inhibitors in the era of closure devices. Catheter Cardiovasc Interv (2003) 1.57
Endovascular repair of a giant carotid pseudoaneurysm with the use of Viabahn stent graft. Catheter Cardiovasc Interv (2004) 1.50
Wireless laser-assisted angioplasty of the superficial femoral artery in patients with critical limb ischemia who have failed conventional percutaneous revascularization. Catheter Cardiovasc Interv (2004) 1.47
Percutaneous repair of abdominal aortic aneurysms using the AneuRx stent graft and the percutaneous vascular surgery device. Catheter Cardiovasc Interv (2002) 1.45
Anatomic versus physiologic assessment of coronary artery disease. Role of coronary flow reserve, fractional flow reserve, and positron emission tomography imaging in revascularization decision-making. J Am Coll Cardiol (2013) 1.44
Quality assessment and improvement in interventional cardiology: a Position Statement of the Society of Cardiovascular Angiography and Interventions, Part II: public reporting and risk adjustment. Catheter Cardiovasc Interv (2011) 1.42
A longitudinal assessment of coronary interventional program quality: a report from the American College of Cardiology-National Cardiovascular Data Registry. JACC Cardiovasc Interv (2009) 1.41
Ex vivo Characterization of Atherosclerosis using Intravascular Photoacoustic Imaging. Opt Express (2007) 1.41
Left ventricular unloading before reperfusion reduces endothelin-1 release and calcium overload in porcine myocardial infarction. J Thorac Cardiovasc Surg (2008) 1.40
Difficult retrieval of the EPI Filterwire with a 5 French FR4 coronary catheter following carotid stenting. Catheter Cardiovasc Interv (2006) 1.40
Single center experience with percutaneous endovascular repair of superior vena cava syndrome. Catheter Cardiovasc Interv (2011) 1.39
Lung cancer after heart transplantation: a 17-year experience. Ann Thorac Surg (2005) 1.39
Catheter-induced dissection of the left main coronary artery with and without extension to the aortic root: a report of two cases and a review of the literature. J Interv Cardiol (2004) 1.39
Feasibility of carotid artery stenting in patients with angiographic string sign. Catheter Cardiovasc Interv (2010) 1.39
Combined cutting balloon angioplasty and intracoronary beta radiation for treatment of in-stent restenosis: clinical outcomes and effect of pullback radiation for long lesions. Catheter Cardiovasc Interv (2002) 1.38
Ischemic time is a better predictor than door-to-balloon time for mortality and infarct size in ST-elevation myocardial infarction. Catheter Cardiovasc Interv (2015) 1.38
Approaches to correct device malposition in percutaneous PFO closure: anatomical and technical implications. Catheter Cardiovasc Interv (2005) 1.38
Is the patient on this team? Int J Radiat Oncol Biol Phys (2003) 1.38
Impact of glomerular filtration rate on clinical outcomes after carotid artery revascularization in 11,832 patients from the CARE registry. Catheter Cardiovasc Interv (2014) 1.38
Assessing myocardial viability and infarct transmurality with left ventricular electromechanical mapping in patients with stable coronary artery disease: validation by delayed-enhancement magnetic resonance imaging. Circulation (2002) 1.36
A randomized study of transendocardial injection of autologous bone marrow mononuclear cells and cell function analysis in ischemic heart failure (FOCUS-HF). Am Heart J (2011) 1.35
Development of a risk adjustment mortality model using the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR) experience: 1998-2000. J Am Coll Cardiol (2002) 1.35
Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery. Circulation (2004) 1.32
Intravascular Photoacoustic Imaging. IEEE J Quantum Electron (2010) 1.32
Effect of no-reflow during primary percutaneous coronary intervention for acute myocardial infarction on six-month mortality. Am J Cardiol (2006) 1.26
Acquired commissural fusion of aortic valves in patients with left ventricular assist devices. J Heart Lung Transplant (2003) 1.22
Remote temperature estimation in intravascular photoacoustic imaging. Ultrasound Med Biol (2007) 1.17
Percutaneous intervention for the treatment of hypoplastic aortoiliac syndrome. Catheter Cardiovasc Interv (2003) 1.13
Results of a multicenter trial for the treatment of traumatic vascular injury with a covered stent. J Trauma (2006) 1.12
Celiac artery aneurysm: a case report. Tex Heart Inst J (2006) 1.11
Acceptance, panic, and partial recovery the pattern of usage of drug-eluting stents after introduction in the U.S. (a report from the American College of Cardiology/National Cardiovascular Data Registry). JACC Cardiovasc Interv (2010) 1.09
Impact of aspirin therapy in cancer patients with thrombocytopenia and acute coronary syndromes. Cancer (2007) 1.08
Long-term outcome of patients treated with repeat percutaneous coronary intervention after failure of gamma-brachytherapy for the treatment of in-stent restenosis. Circulation (2002) 1.08
Percutaneous coronary interventions in facilities without cardiac surgery on site: a report from the National Cardiovascular Data Registry (NCDR). J Am Coll Cardiol (2009) 1.07
Spectrum of aortic operations in 300 patients with confirmed or suspected Marfan syndrome. Ann Thorac Surg (2006) 1.06
Cyclooxygenase-2 inhibitor treatment improves left ventricular function and mortality in a murine model of doxorubicin-induced heart failure. Circulation (2004) 1.05
Current expectations for newborns undergoing the arterial switch operation. Ann Surg (2004) 1.05
Novel anti-factor D monoclonal antibody inhibits complement and leukocyte activation in a baboon model of cardiopulmonary bypass. Ann Thorac Surg (2002) 1.04
Common artifacts in PET myocardial perfusion images due to attenuation-emission misregistration: clinical significance, causes, and solutions. J Nucl Med (2004) 1.04
Percutaneous coronary intervention and drug-eluting stent use among patients ≥85 years of age in the United States. J Am Coll Cardiol (2012) 1.03
Concomitant brachiocephalic and coronary artery disease: outcome and decision analysis. Ann Thorac Surg (2005) 1.02
Delayed spinal cord deficits after thoracoabdominal aortic aneurysm repair. Ann Thorac Surg (2007) 1.02
Combined intense lifestyle and pharmacologic lipid treatment further reduce coronary events and myocardial perfusion abnormalities compared with usual-care cholesterol-lowering drugs in coronary artery disease. J Am Coll Cardiol (2003) 1.01
Clopidogrel and bleeding in patients undergoing elective coronary artery bypass grafting. J Thorac Cardiovasc Surg (2004) 1.01
The impact of hypogonadism and autonomic dysfunction on fatigue, emotional function, and sexual desire in male patients with advanced cancer: a pilot study. Cancer (2006) 1.00
Feasibility of in vivo intravascular photoacoustic imaging using integrated ultrasound and photoacoustic imaging catheter. J Biomed Opt (2012) 0.99
Catheter-based transendocardial delivery of autologous bone-marrow-derived mononuclear cells in patients listed for heart transplantation. Tex Heart Inst J (2004) 0.98
Trends in the association between age and in-hospital mortality after percutaneous coronary intervention: National Cardiovascular Data Registry experience. Circ Cardiovasc Interv (2009) 0.97
Contemporary results of endovascular repair of abdominal aortic aneurysms: effect of anatomical fixation on outcomes. J Endovasc Ther (2010) 0.97
Left ventricular unloading alters receptor tyrosine kinase expression in the failing human heart. J Heart Lung Transplant (2002) 0.97
Initial report of percutaneous right ventricular assist for right ventricular shock secondary to right ventricular infarction. Catheter Cardiovasc Interv (2006) 0.96
Mortality after emergent percutaneous coronary intervention in cardiogenic shock secondary to acute myocardial infarction and usefulness of a mortality prediction model. Am J Cardiol (2005) 0.95
Clinical referral patterns for carotid artery stenting versus carotid endarterectomy: results from the Carotid Artery Revascularization and Endarterectomy Registry. Circ Cardiovasc Interv (2011) 0.95
Brachiocephalic reconstruction II: operative and endovascular management of single-vessel disease. J Vasc Surg (2005) 0.94
Endovascular exclusion of popliteal artery aneurysms with stent-grafts: a prospective single-center experience. J Endovasc Ther (2009) 0.94
Hospital percutaneous coronary intervention appropriateness and in-hospital procedural outcomes: insights from the NCDR. Circ Cardiovasc Qual Outcomes (2012) 0.94
Cardioembolic stroke. Curr Atheroscler Rep (2006) 0.93
Correlation of periprocedural systolic blood pressure changes with neurological events in high-risk carotid stent patients. J Endovasc Ther (2002) 0.92
The MBL2 'LYQA secretor' haplotype is an independent predictor of postoperative myocardial infarction in whites undergoing coronary artery bypass graft surgery. Circulation (2007) 0.92
Updated risk adjustment mortality model using the complete 1.1 dataset from the American College of Cardiology National Cardiovascular Data Registry (ACC-NCDR). J Invasive Cardiol (2003) 0.92
Technical tips for endovascular treatment of abdominal aortic aneurysms with challenging infrarenal neck anatomy using the Excluder endoprosthesis. J Endovasc Ther (2010) 0.91
Predictors of carotid stent restenosis. Catheter Cardiovasc Interv (2007) 0.90
Do postmarketing surveillance studies represent real-world populations? A comparison of patient characteristics and outcomes after carotid artery stenting. Circulation (2011) 0.90
Aortic wrap as a novel technique of type I endoleak repair. Ann Vasc Surg (2006) 0.90
Milestones in the treatment of aortic aneurysm: Denton A. Cooley, MD, and the Texas Heart Institute. Tex Heart Inst J (2005) 0.90
Images in cardiovascular medicine. Percutaneous heart valve in the chronic in vitro testing model. Circulation (2002) 0.90
ACC/AHA/SCAI 2014 health policy statement on structured reporting for the cardiac catheterization laboratory: a report of the American College of Cardiology Clinical Quality Committee. J Am Coll Cardiol (2014) 0.89
Regional variation: only moderately interesting: a word of caution. Circ Cardiovasc Qual Outcomes (2010) 0.89